Abstract | OBJECTIVE: The National Heart, Lung, and Blood Institute, of The National Institutes of Health, convened the 2012 State-of-the-Science Symposium in therapeutic apheresis (TA) with the goals of identifying and prioritizing future research concept proposals to optimize the use of TA over the next decade. METHODS: Six subcommittees, including neurology, were formed based on organ system, pathophysiology, and technology/special considerations. The subcommittees consisted of physicians, clinical subject matter experts, and basic scientists. Each subcommittee developed concept proposals that were presented, evaluated, and prioritized based on scientific importance, clinical significance, and feasibility. RESULTS: CONCLUSIONS: Key clinical research priorities to evaluate and optimize the use of TA on selected neurologic disorders exist. The research opportunities if addressed would provide evidence-based data to inform the care of patients with these selected neurologic diseases.
|
Authors | Shanna M Morgan, Beth H Shaz, Katerina Pavenski, Erin K Meyer, Meghan Delaney, Zbigniew M Szczepiorkowski |
Journal | Journal of clinical apheresis
(J Clin Apher)
Vol. 29
Issue 6
Pg. 331-5
(Dec 2014)
ISSN: 1098-1101 [Electronic] United States |
PMID | 24899381
(Publication Type: Congress)
|
Copyright | © 2014 Wiley Periodicals, Inc. |
Chemical References |
- Immunoglobulins, Intravenous
|
Topics |
- Autoimmune Diseases of the Nervous System
(therapy)
- Biological Specimen Banks
(organization & administration)
- Blood Component Removal
- Clinical Trials as Topic
- Encephalomyelitis, Acute Disseminated
(therapy)
- Hearing Loss, Sensorineural
(therapy)
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Multiple Sclerosis, Relapsing-Remitting
(therapy)
- Myasthenia Gravis
(therapy)
- National Heart, Lung, and Blood Institute (U.S.)
- Neuromyelitis Optica
(therapy)
- Photopheresis
- Plasma Exchange
- Polymyositis
(therapy)
- Registries
- Research Design
- United States
|